163 related articles for article (PubMed ID: 29441684)
1. Development of drug discovery screening system by molecular interaction kinetics-mass spectrometry.
Obi N; Fukuda T; Nakayama N; Ervin J; Bando Y; Nishimura T; Nagatoishi S; Tsumoto K; Kawamura T
Rapid Commun Mass Spectrom; 2018 Apr; 32(8):665-671. PubMed ID: 29441684
[TBL] [Abstract][Full Text] [Related]
2. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA
J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis and fragment screening with Fujifilm AP-3000.
Rich RL; Myszka DG
Anal Biochem; 2010 Jul; 402(2):170-8. PubMed ID: 20371220
[TBL] [Abstract][Full Text] [Related]
4. Label-free characterization of carbonic anhydrase-novel inhibitor interactions using surface plasmon resonance, isothermal titration calorimetry and fluorescence-based thermal shift assays.
Rogez-Florent T; Duhamel L; Goossens L; Six P; Drucbert AS; Depreux P; Danzé PM; Landy D; Goossens JF; Foulon C
J Mol Recognit; 2014 Jan; 27(1):46-56. PubMed ID: 24375583
[TBL] [Abstract][Full Text] [Related]
5. Free-solution interaction assay of carbonic anhydrase to its inhibitors using back-scattering interferometry.
Morcos EF; Kussrow A; Enders C; Bornhop D
Electrophoresis; 2010 Nov; 31(22):3691-5. PubMed ID: 20972990
[TBL] [Abstract][Full Text] [Related]
6. A capillary electrophoresis-based enzyme assay for kinetics and inhibition studies of carbonic anhydrase.
Iqbal S; Nisar-ur-Rahman ; Iqbal J
Anal Biochem; 2014 Jan; 444():16-21. PubMed ID: 24064297
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based monitoring of millisecond protein-ligand binding dynamics using an automated microfluidic platform.
Cong Y; Katipamula S; Trader CD; Orton DJ; Geng T; Baker ES; Kelly RT
Lab Chip; 2016 Apr; 16(9):1544-8. PubMed ID: 27009517
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study.
Barrese AA; Genis C; Fisher SZ; Orwenyo JN; Kumara MT; Dutta SK; Phillips E; Kiddle JJ; Tu C; Silverman DN; Govindasamy L; Agbandje-McKenna M; McKenna R; Tripp BC
Biochemistry; 2008 Mar; 47(10):3174-84. PubMed ID: 18266323
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase II binds to and increases the activity of the epithelial sodium-proton exchanger, NHE3.
Krishnan D; Liu L; Wiebe SA; Casey JR; Cordat E; Alexander RT
Am J Physiol Renal Physiol; 2015 Aug; 309(4):F383-92. PubMed ID: 26041446
[TBL] [Abstract][Full Text] [Related]
10. Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.
Poli G; Jha V; Martinelli A; Supuran CT; Tuccinardi T
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937490
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.
Kaya M; Basar E; Cakir E; Tunca E; Bülbül M
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):509-14. PubMed ID: 21846203
[TBL] [Abstract][Full Text] [Related]
12. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.
Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT
Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737
[TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology.
Cannon MJ; Papalia GA; Navratilova I; Fisher RJ; Roberts LR; Worthy KM; Stephen AG; Marchesini GR; Collins EJ; Casper D; Qiu H; Satpaev D; Liparoto SF; Rice DA; Gorshkova II; Darling RJ; Bennett DB; Sekar M; Hommema E; Liang AM; Day ES; Inman J; Karlicek SM; Ullrich SJ; Hodges D; Chu T; Sullivan E; Simpson J; Rafique A; Luginbühl B; Westin SN; Bynum M; Cachia P; Li YJ; Kao D; Neurauter A; Wong M; Swanson M; Myszka DG
Anal Biochem; 2004 Jul; 330(1):98-113. PubMed ID: 15183767
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new carbonic anhydrase inhibitors.
Xiao Z; Duan R; Cui W; Zhang Y; Zhang S; Chen F; Zhang Y; Liu J; Zhang D; Meng Y; Wang L; Wang H
Bioorg Med Chem; 2011 May; 19(10):3221-8. PubMed ID: 21524585
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of N-heteroarylsubstituted triazolosulfonamides as carbonic anhydrase inhibitors.
Balci A; Arslan M; Nixha AR; Bilen C; Ergun A; Gençer N
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):377-82. PubMed ID: 25068730
[TBL] [Abstract][Full Text] [Related]
16. Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds.
Iyer R; Barrese AA; Parakh S; Parker CN; Tripp BC
J Biomol Screen; 2006 Oct; 11(7):782-91. PubMed ID: 16858005
[TBL] [Abstract][Full Text] [Related]
17. A class of sulfonamides as carbonic anhydrase I and II inhibitors.
Gokcen T; Gulcin I; Ozturk T; Goren AC
J Enzyme Inhib Med Chem; 2016; 31(sup2):180-188. PubMed ID: 27353698
[TBL] [Abstract][Full Text] [Related]
18. Probing the energetics of dissociation of carbonic anhydrase-ligand complexes in the gas phase.
Gao J; Wu Q; Carbeck J; Lei QP; Smith RD; Whitesides GM
Biophys J; 1999 Jun; 76(6):3253-60. PubMed ID: 10354450
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II.
Büyükkıdan N; Büyükkıdan B; Bülbül M; Kasımoğulları R; Mert S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):208-213. PubMed ID: 28114829
[TBL] [Abstract][Full Text] [Related]
20. Developments of mass spectrometry-based technologies for effective drug development linked with clinical proteomes.
Nakayama N; Bando Y; Fukuda T; Kawamura T; Nakamura H; Marko-Varga G; Nishimura T
Drug Metab Pharmacokinet; 2016 Feb; 31(1):3-11. PubMed ID: 26782309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
